Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Sigma Healthcare Ltd ( (AU:SIG) ) just unveiled an update.
Sigma Healthcare has advised that it will publish its FY26 half-year financial results for the period ending 31 December 2025 to the ASX on the morning of Thursday, 26 February 2026. The company will follow the release with an investor webcast presentation at 10:00am AEDT on the same day, with access details to be provided closer to the date and made available via its investor relations website, signalling its ongoing engagement with investors and the market ahead of the interim results.
The most recent analyst rating on (AU:SIG) stock is a Buy with a A$3.39 price target. To see the full list of analyst forecasts on Sigma Healthcare Ltd stock, see the AU:SIG Stock Forecast page.
More about Sigma Healthcare Ltd
Sigma Healthcare Limited is an Australian healthcare company listed on the ASX, operating within the pharmaceutical and healthcare sector, with a focus on supplying products and services to the broader healthcare market.
Average Trading Volume: 15,729,911
Technical Sentiment Signal: Buy
Current Market Cap: A$33.19B
Find detailed analytics on SIG stock on TipRanks’ Stock Analysis page.